Concepedia

Kenneth J. Shaw

KJ

Statistics

Publications

27

Citations

2.3K

H-Index

20

Active since

1983

Affiliations

Virginia BioTechnology Research Park(Current)

BD Biosciences (United States)

Janssen (United States)

WuXi AppTec (China)

Exelixis (United States)

Kenneth J. Shaw is an author at Virginia BioTechnology Research Park specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1983–2020

27

Publications

27

Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome

Annette L. Parks, Kevin R Cook, Marcia Belvin et al. · Nature Genetics · 2004 · 774 citations

, , +15

Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.

Diane Pennica, K. L. King, Kenneth J. Shaw et al. · Proceedings of the National Academy of Sciences · 1995 · 558 citations

, , +16

Routes to mitomycins. Chirospecific synthesis of aziridinomitosenes

Kenneth J. Shaw, Jay R. Luly, Henry Rapoport · The Journal of Organic Chemistry · 1985 · 139 citations

, , +5

Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors

Zuchun Zhao, Damian O. Arnaiz, Brian D. Griedel et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 105 citations · Full text

, , +10

Discovery of XL413, a potent and selective CDC7 inhibitor

Elena S. Koltun, Amy Lew Tsuhako, David S. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 92 citations · Full text

, , +9

1–5 of 27